DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award
Defense Health Agency Contracting Activity - DHACA
Program funding
$1,950,000
- Opportunity #
- HT942526LCRPPCOSA
- Agency
- Defense Health Agency Contracting Activity - DHACA
- ALN (CFDA)
- 12.420
- Status
- posted
- Posted
- May 5, 2026
- Closes
- Sep 2, 2026
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Cost sharing required
- No
Who can apply
- •Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Synopsis
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.
Distinctive Features:
• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.
• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.
Contact
Danielle Reckley Grantor · help@eBRAP.org